|
Post by silentbob on Mar 8, 2014 6:03:18 GMT -5
Thanks Rak!
I will make mor time for the upcoming material events; the ADCOM docs & meeting itself, PDUFA, and partnership.
At that point we can talk about facts, instead of scaring people with all the things that could go wrong. I am way too good at finding those.
|
|
|
Post by afrezzapizza on Mar 12, 2014 9:52:38 GMT -5
|
|
|
Post by thekindaguyiyam on Mar 12, 2014 10:37:51 GMT -5
who knows if they are even real. Novo staff could be writing those all day long. My guess is that the same people who are fearful of new technology or afraid to leave the needle also don't use nasal spray when they are congested. Keep up the good work! And many thanks for your contributions.
|
|
|
Post by brentie on Mar 12, 2014 11:27:05 GMT -5
We're finally starting to get some good feedback. Reply by Lilli D 1 hour ago I've read a lot about afrezza and would definitely like it to come to market, I already told my doctor I'd like to try it when it does. My only BG issue currently is post prandial, I have very little first phase release. I have no problem with needles but my research indicates afrezza's quick mechanism of action (and short duration of action) sounds like it would be much easier to control than current short acting insulins and would much more closely mimic meal-time insulin release. I am currently using prandin and recently trying metformin to try to regulate mealtime hyperglycemia. For someone like me, afrezza would be an opportunity to replace my missing first phase release in a much more controllable and measured way rather than using the prandon which stimulates my own insulin release. I'm in! ▶ Reply Permalink Reply by Patricia 8 minutes ago I would love an option for safe precise & effective delivery of inhaled insulin. I believe that an inhaled insulin may have the potential to peak faster and possibly eliminate higher blood sugars after meals. It's not a comfortable idea for a Type1's blood sugar to be acceptable at 180 3 hrs after a meal. Plus the highs make you feel tired and mentally less on your game. A medication that could target post prandial elevations & somatic discomfort associated would be an advantage in the immediate as well as in prevention of LTC. Permalink Reply by Linda 32 minutes ago I've been T1D for 53 years and currently on a pump. I would welcome an inhaled fast acting insulin but would only use it (assuming it's faster acting than Humalog) when my bg is unusually high and would be benefited more by a delivery method that may get my bg to respond more quickly. Otherwise my control is good and I'm slightly concerned about my lungs as others have voiced.
|
|
|
Post by babaoriley on Mar 12, 2014 12:14:27 GMT -5
Do Lilli, Patricia and Linda all work in Valencia?
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Mar 12, 2014 16:44:22 GMT -5
Sounds like Manny (the guy going to speak) is not negative.
|
|